Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (321-330 of 953) with videos related to

Pageof 96
Sort By:
Journal of Alzheimer'S Disease : JAD|December 31, 2014
Amyloid-β oligomers relate to cognitive decline in Alzheimer's diseaseWesley Jongbloed, Kim A Bruggink, Maartje I Kester, et al.
Alzheimer'S Research & Therapy|December 6, 2014
The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trialNiels D Prins, Wiesje A van der Flier, Dirk L Knol, et al.
Journal of the American Geriatrics Society|June 7, 2019
White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ StudyNienke Legdeur, Pieter Jelle Visser, Davis C Woodworth, et al.
Neurology|July 4, 2019
Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationshipAnna Catharina van Loenhoud, Wiesje Maria van der Flier, Alle Meije Wink, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET statusEline A J Willemse, Betty M Tijms, Bart N M van Berckel, et al.
Molecular Imaging and Biology|April 6, 2012
P-glycoprotein function at the blood-brain barrier: effects of age and genderDaniëlle M E van Assema, Mark Lubberink, Ronald Boellaard, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 5, 2007
Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairmentMarc A Kropholler, Ronald Boellaard, Bart N M van Berckel, et al.
Archives of Neurology|January 11, 2007
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementiaCharles DeCarli, Giovanni B Frisoni, Christopher M Clark, et al.
Stroke|January 24, 2009
Regional white matter integrity differentiates between vascular dementia and Alzheimer diseaseMojtaba Zarei, Jeske S Damoiseaux, Ciro Morgese, et al.
Neurology|September 20, 2013
Preclinical AD predicts decline in memory and executive functions in subjective complaintsArgonde C van Harten, Lieke L Smits, Charlotte E Teunissen, et al.
Pageof 96

Showing results (321-330 of 953) with videos related to

Sort By:
Pageof 96
Journal of Alzheimer'S Disease : JAD|December 31, 2014
Amyloid-β oligomers relate to cognitive decline in Alzheimer's diseaseWesley Jongbloed, Kim A Bruggink, Maartje I Kester, et al.
Alzheimer'S Research & Therapy|December 6, 2014
The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trialNiels D Prins, Wiesje A van der Flier, Dirk L Knol, et al.
Journal of the American Geriatrics Society|June 7, 2019
White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ StudyNienke Legdeur, Pieter Jelle Visser, Davis C Woodworth, et al.
Neurology|July 4, 2019
Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationshipAnna Catharina van Loenhoud, Wiesje Maria van der Flier, Alle Meije Wink, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET statusEline A J Willemse, Betty M Tijms, Bart N M van Berckel, et al.
Molecular Imaging and Biology|April 6, 2012
P-glycoprotein function at the blood-brain barrier: effects of age and genderDaniëlle M E van Assema, Mark Lubberink, Ronald Boellaard, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 5, 2007
Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairmentMarc A Kropholler, Ronald Boellaard, Bart N M van Berckel, et al.
Archives of Neurology|January 11, 2007
Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementiaCharles DeCarli, Giovanni B Frisoni, Christopher M Clark, et al.
Stroke|January 24, 2009
Regional white matter integrity differentiates between vascular dementia and Alzheimer diseaseMojtaba Zarei, Jeske S Damoiseaux, Ciro Morgese, et al.
Neurology|September 20, 2013
Preclinical AD predicts decline in memory and executive functions in subjective complaintsArgonde C van Harten, Lieke L Smits, Charlotte E Teunissen, et al.
Pageof 96